CDC National Infection Control Strengthening . . | CDC RFA CK19 1905

Opportunity Information: Apply for CDC RFA CK19 1905

The CDC National Infection Control Strengthening opportunity (Funding Opportunity Number CDC-RFA-CK19-1905) is a cooperative agreement from the Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), within NCEZID, focused on strengthening national infection control capacity by building on hard-won expertise from the US Ebola response. The core idea is that the best public health return comes from supporting a small, highly specialized set of institutions that have already demonstrated they can safely treat Ebola patients, translate those lessons into practical infection prevention and control improvements, and train other health care facilities to manage both Ebola and healthcare-associated infections (HAIs). Rather than funding broad, general-purpose hospital preparedness efforts, this program is designed to leverage a unique consortium model where proven leaders jointly develop and implement projects that improve readiness for Ebola Hemorrhagic Fever (EHF) and strengthen infection control systems that also reduce HAIs.

A key emphasis of the opportunity is coordinated, collaborative project development among a limited group of expert institutions with real-world treatment experience and the operational infrastructure to implement solutions quickly. CDC notes that when several established leaders work together, they can build on existing foundations, avoid reinventing work, and produce tangible benefits to public health, including improved national capabilities for infection control and high-consequence pathogen readiness. The announcement also stresses the importance of planning in advance and coordinating applications with other awardees connected to FOA EP-U3R-15-003, so that funded activities are complementary and synergistic rather than duplicative. This coordination requirement reflects a practical constraint: the work must be feasible and deliver results within a short project time frame, so overlapping efforts would waste time and reduce impact.

The opportunity is closely tied to the National Ebola Training and Education Center (NETEC) concept: using strong existing and new partnerships with federal agencies to strengthen both the health care delivery system and public health preparedness for the next emerging infectious disease threat. In CDC's framing, investing in this specialized consortium improves readiness not just for Ebola, but for future high-consequence infectious disease events, because many of the same infection control capabilities (PPE programs, isolation procedures, environmental decontamination, training and competency assessment, safe specimen handling, and related operational practices) also drive broader reductions in HAIs and improve system resilience.

Eligibility is listed broadly as nonprofit organizations with 501(c)(3) status (other than institutions of higher education), private institutions of higher education, and other eligible entities as described in the opportunity's additional eligibility text. At the same time, the description makes clear that CDC views this as a uniquely positioned consortium with unparalleled access to the required facilities and expertise, explicitly naming three institutions as the core members: Emory University, the University of Nebraska Medical Center/Nebraska Medicine, and New York City Health and Hospitals/Bellevue. The rationale is that these organizations and their working groups have capabilities and experience that other institutions generally do not, particularly regarding hands-on Ebola treatment experience alongside deep infection prevention and control expertise related to HAIs.

From a funding and administrative standpoint, the instrument is a cooperative agreement, which typically means CDC expects substantial involvement in guiding, coordinating, and collaborating on the work rather than simply issuing a grant with minimal federal interaction. The opportunity falls under the health activity category and is associated with CFDA number 93.825. The posted award ceiling is $4,100,000, with an expectation of three awards, aligning with the three named consortium institutions. The opportunity was created on July 3, 2019, with an original application due date of August 5, 2019 (11:59 p.m. ET for electronic submissions).

• The Department of Health and Human Services, Centers for Disease Control - NCEZID in the health sector is offering a public funding opportunity titled "CDC National Infection Control Strengthening . ." and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.825.
• This funding opportunity was created on Jul 03, 2019.
• Applicants must submit their applications by Aug 05, 2019 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $4,100,000.00 in funding.
• The number of recipients for this funding is limited to 3 candidate(s).
• Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA CK19 1905

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: